Will Junker, head of manufacturing quality at Kite Pharma, talks to Cell & Gene: The Podcast listeners about the challenges associated with capacity planning, partnering with CDMOs, and prioritizing inventory over time-to-market. Learn why a better understanding of the vector manufacturing process is critical to bringing continuous and secure supply to market. Listen now and subscribe so you never miss an episode!
The industry is now considering non-animal methods for toxicology studies. The move is toward more predictive models such as machine learning and organ-on-a-chip to drive safer and more efficient science.